Evaxion Biotech A/S (EVAX) News Today

$0.62

-0.20 (-24.48%)

(As of 12/5/2023 ET)

Today's Range: $0.55
▼
$0.77
50-Day Range: $0.62
▼
$1.17
52-Week Range: $0.47
▼
$2.44

Volume: 763,628 shs
Average Volume: 275,507 shs
Market Capitalization: $17.23 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $7.00

Source

Source	Headline
	Short Interest in Evaxion Biotech A/S (NASDAQ:EVAX) Declines By 22.8% americanbankingnews.com - December 3 at 1:42 AM
	Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept finance.yahoo.com - November 28 at 8:40 AM
	Evaxion Presents Proof-of-Principle for Its Unique AI Model Predicting Responses to Cancer Immunotherapy finance.yahoo.com - November 15 at 8:55 AM
	ADRs End Lower; Evaxion Biotech A/S Declines 30% morningstar.com - November 9 at 6:19 PM
	Evaxion Shares Latest EVX-01 Phase 2 Clinical Data in Webinar with Key Opinion Leader Adnan Khattak finance.yahoo.com - November 6 at 2:49 PM
	ADRs Hold Steady; Fresh2 Group Climbs 23% morningstar.com - October 31 at 6:20 PM
	Evaxion Biotech: Evaxion Announces Encouraging Initial Phase 2 Clinical Data on Its Personalized Cancer Vaccine EVX-01 finanznachrichten.de - October 31 at 1:20 PM
	Evaxion Announces Encouraging Initial Phase 2 Clinical Data on Its Personalized Cancer Vaccine EVX-01 finance.yahoo.com - October 31 at 1:20 PM
	Evaxion Biotech: New and Exciting Clinical Data on Evaxion's AI-Immunology-Based Personalized Cancer Vaccines to be Presented finanznachrichten.de - October 26 at 1:07 PM
	New and Exciting Clinical Data on Evaxion's AI-Immunology™-Based Personalized Cancer Vaccines to be Presented tmcnet.com - October 26 at 1:07 PM
	New and Exciting Clinical Data on Evaxion’s AI-Immunology™-Based Personalized Cancer Vaccines to be Presented finance.yahoo.com - October 26 at 1:07 PM
	Evaxion Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency finance.yahoo.com - October 5 at 10:00 AM
	Evaxion (EVAX) Up on Partnership With Afrigen for Gonorrhea Jab finance.yahoo.com - September 21 at 5:11 PM
	Evaxion Biotech: Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea finanznachrichten.de - September 20 at 3:29 PM
	Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea finance.yahoo.com - September 20 at 10:29 AM
	Evaxion expands preclinical bacterial vaccine pipeline in collaboration with leading pharmaceutical company finance.yahoo.com - September 18 at 10:08 AM
	Novo Buys Embark Biotech to Find New Avenues for Weight Loss bloomberg.com - August 30 at 8:00 AM
	Evaxion Biotech: Evaxion announces Executive Management Changes to strengthen the AI-strategy finanznachrichten.de - August 29 at 11:57 AM
	Evaxion announces Executive Management Changes to strengthen the AI-strategy finance.yahoo.com - August 29 at 11:57 AM
	European Equities Traded in the US as American Depositary Receipts Rising, Backed by Mostly Firmer Markets msn.com - August 24 at 8:57 AM
	Evaxion Biotech A/S (NASDAQ:EVAX) Q2 2023 Earnings Call Transcript finance.yahoo.com - August 23 at 5:48 PM
	Q2 2023 Evaxion Biotech A/S Earnings Call finance.yahoo.com - August 23 at 3:22 AM
	Evaxion Biotech: Evaxion Announces Business Update and Second Quarter 2023 Financial Results finanznachrichten.de - August 18 at 5:57 PM
	Evaxion Announces Business Update and Second Quarter 2023 Financial Results finance.yahoo.com - August 18 at 5:57 PM
	Evaxion Biotech: Personalized Cancer Vaccine Biotech With Q4 2023 Catalyst msn.com - August 3 at 12:11 PM
	Evaxion gets $20M financing from Negma msn.com - August 1 at 9:43 PM
	Evaxion announces financing commitments totaling up to USD 20 million with Negma Group finance.yahoo.com - August 1 at 11:30 AM
	Evaxion presents promising results on EVX-B1, an AI-designed vaccine against Staphylococcus aureus finance.yahoo.com - July 31 at 11:44 AM
	Iovance Biotherapeutics: More Than A One-Shot Wonder seekingalpha.com - July 10 at 10:46 PM
	Thermo Fisher to buy Audax’s CorEvitas for $913M axios.com - July 8 at 3:19 AM
	Cancer drug firms soar as positive clinical trial data ignites investor excitement foxnews.com - June 8 at 11:49 AM
	ADRs End Mostly Lower, BiondVax, Evaxion Biotech Trade Actively marketwatch.com - June 5 at 10:01 PM
	Cancer drugmakers rise as industry meet fuels investor interest news.yahoo.com - June 5 at 12:01 PM
	Evaxion Biotech Shares Rise 38% After Positive EVX-01 Phase 1 Trial Data marketwatch.com - June 5 at 12:01 PM
	Why Are Evaxion Biotech Shares Trading Higher Today finance.yahoo.com - June 5 at 12:01 PM
	Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial finance.yahoo.com - June 3 at 9:03 PM
	European Equities Recover Some Losses in Thursday Trading msn.com - June 1 at 1:16 PM
	Analysts Expect Breakeven For Evaxion Biotech A/S (NASDAQ:EVAX) Before Long finance.yahoo.com - June 1 at 8:15 AM
	Evaxion Announces Business Update and First Quarter 2023 Financial Results finance.yahoo.com - May 31 at 11:04 AM
	Evaxion announces promising clinical Phase 1 data for its personalized cancer vaccine EVX-01 finance.yahoo.com - May 25 at 7:09 PM
	Elan's Martin Named Worst Biotech CEO of '08 thestreet.com - May 21 at 8:29 PM
	Evaxion to host R&D Day on May 25, 2023 finance.yahoo.com - May 16 at 8:49 AM
	Fourth quarter and full year 2022 financial results and business update finance.yahoo.com - April 27 at 9:51 AM
	Evaxion Biotech Says Personalized Cancer Immunotherapy Meets Primary Endpoint In Melanoma Patients msn.com - April 18 at 9:21 PM
	Evaxion announces promising clinical data for DNA-based personalized cancer immunotherapy EVX-02: Phase 1/2a trial met both primary and secondary endpoints finance.yahoo.com - April 18 at 9:57 AM
	Evaxion Biotech: Evaxion and Pennsylvania State University publish preclinical data validating our AI-based viral vaccine discovery platform finanznachrichten.de - April 14 at 6:53 PM
	Evaxion and Pennsylvania State University publish preclinical data validating our AI-based viral vaccine discovery platform finance.yahoo.com - April 13 at 12:51 PM
	Lake Street Keeps Their Buy Rating on Evaxion Biotech (EVAX) markets.businessinsider.com - March 31 at 12:47 PM
	Evaxion Biotech: Evaxion Announces Increased Focus and Fast-Tracking of its New AI Discovery to Patients finanznachrichten.de - March 28 at 10:31 AM
	Evaxion Announces Increased Focus and Fast-Tracking of its New AI Discovery to Patients finance.yahoo.com - March 28 at 10:31 AM

Get Evaxion Biotech A/S News Delivered to You Automatically

EVAX Media Mentions By Week

EVAX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EVAX
News Sentiment
▼
0.93

0.39
▲
Average
Medical
News Sentiment

EVAX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EVAX Articles
This Week
▼
2

1
▲
EVAX Articles
Average Week

Get Evaxion Biotech A/S News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:EVAX) was last updated on 12/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Evaxion Biotech A/S (EVAX) News Today

EVAX Media Mentions By Week

EVAX Media Sentiment

EVAX News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info